Author Archives: admin


The Skin Center brings its aesthetic expertise to Murrysville, PA with a new state-of-the-art medical spa. – 69News WFMZ-TV

MURRYSVILLE, Pa., April 12, 2022 /PRNewswire/ -- The Skin Center, Pittsburgh's leading medical spa, is set to open a new state-of-the-art clinic in Murrysville, PA on April 18, 2022. "We are thrilled to bring our aesthetic expertise to Murrysville," says Greg Sanker, CEO at The Skin Center. "We have a long, trusted history in the Pittsburgh community and remain committed to being the premier provider of cosmetic services and raising the bar in our industry," says Sanker. The new medical spa is conveniently located in the Blue Spruce Shoppes on Route 22 in Murrysville, PA.

The Skin Center's most popular aesthetic treatments are Botox and dermal fillers, and it is recognized as a Top 10 Partner Provider in the nation by Allergan Aesthetics, the maker of Botox and Juvderm dermal fillers. "Our approach is as collaborative as it is rooted in clinical excellence," says Sanker. "Our licensed expert providers have exceptional training, experience, temperament and intuition, qualities that we believe translate to superior patient outcomes," he says.

The new Murrysville medical spa will also feature a curated selection of the latest FDA-approved aesthetic technologies, including CoolSculpting Elite, a non-invasive body contouring treatment proven to reduce up to 25% of fat cells in a treated area. The Skin Center is the only aesthetic clinic in the Pittsburgh area to offer CoolSculpting Elite. Other services offered include platelet-rich plasma (PRP) injections, microneedling and laser hair removal.

Murrysville Grand Opening Specials

Patients can book appointments now to take advantage of these grand opening promotions, which expire on May 31st:

About The Skin Center

The Skin Center ("TSC") was founded over 40 years ago in Pittsburgh, PA and has served over 500,000 patients since its founding. As a leader in aesthetic services, The Skin Center is a top provider of injectables nationally, maintains the latest non-invasive skin rejuvenation and body contouring technologies on the market, and is skilled in the art of cosmetic and plastic surgery. The TSC team includes three board-certified surgeons and 39 skincare experts, including skilled providers, medical aestheticians, and body contouring specialists. The company maintains eight locations across Pennsylvania and Ohio. Learn more about The Skin Center at http://www.theskincentermd.com.

Follow The Skin Center on Social!

Instagram https://www.instagram.com/theskincentermd/

Facebook https://www.facebook.com/theskincentermd

Contact Information:

The Skin Center

Zachary Cole, Sr. Marketing Manager

412-429-1151

Zcole@theskincentermd.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-skin-center-brings-its-aesthetic-expertise-to-murrysville-pa-with-a-new-state-of-the-art-medical-spa-301524170.html

SOURCE The Skin Center

More here:
The Skin Center brings its aesthetic expertise to Murrysville, PA with a new state-of-the-art medical spa. - 69News WFMZ-TV

Anti-aging treatments by experts for women in their 40’s – India TV News

Image Source : FREEPIK

Anti-aging treatments by experts for women in their 40's

As we age there are many problems which we start to see especially in the face region. The two main issues that happen are sagging and loss of volume. Plus there are wrinkles that are seen on the forehead and side of the eyes giving a tired look to the face. If any person has a loss of volume this causes the face to look droopy. The options to restore volume are either HA (hyaluronic acid) fillers, which are a gel-like substance or our own fat.

These HA fillers last for 10-12 months and slowly dissolve in the body and need to be done again. Fat remains for 3-4 years at least and gives a very good improvement in skin texture as well!

Sagging happens as we age due to tissues losing their tone. There is a constant process of sagging that starts from the 30s and goes up as we age. The latest treatment option for correcting the sagging is by use of COG threads. These threads are made of a dissolving material called PLA which remains for 1.5-2 years. This thread lifting is done under local anaesthesia and needs only 2-3 days of recovery time.

For advanced sagging of the face in older people, we have to do a surgery called facelift and neck lift. This gives a very good improvement in facial appearance and makes a person look 15-20 years younger. Though surgical procedures have a downtime of 3-4 weeks for recovery, the result lasts for many years.

Wrinkles are caused by the action of specific muscles. These can be eliminated by injection of botulinum toxin ( Botox) in specific areas. It keeps you looking fresh and young much longer. It can also prevent or push back a facelift for decadesespecially when combined with a good sunscreen and skincare regimen. This remains effective for 6-8 months and then needs to be repeated. These injections are very safe and give a good anti-ageing effect due to the loss of wrinkles.

The latest advances in anti-ageing are Nano-fat injections and PRP. PRP Microneedling along with PRP rejuvenation. The treatment increases your natural collagen which helps firm the skin, fine lines, and sun damage. It has been a game-changer for my patients in their 40s that desire a long-term investment into their skin health. Our own fat and blood have a lot of regenerative cells. In Nano-fat treatment, a small amount of our fat is removed using a tiny needle, it is processed and the concentrate is injected in specific areas of the face to improve wrinkles, sagging and under-eye dark circles. Similarly, our own blood can be processed to get Platelet-rich plasma ( PRP) and inject this into specific areas of the face for anti ageing effect.

Aptos Threads are a great treatment to rejuvenate skin. When placed superficially, the threads act as a support system for thin or sagging skin while promoting collagen production. The threads also can improve redness and brown spots. In addition, threads can be placed anywhere on the face, neck, or chest. In combination with deep threads, which lift without adding volume, it can make a huge difference for over 40 skin.

Fractionated CO2 Laser Skin Resurfacing is another one of the most popular anti-ageingtreatments. This treatment literally erases wrinkles. It helps to treat sun damage and collagen formation and gives you better-looking skin. It helps make the skin look younger after 40.

There are a lot of advanced laser treatments, face tightening machines such as HIFU (High-Intensity Focussed Ultrasound) and Ultherapy which also give a good effect on skin laxity. Ultherapy works best for the loose skin on the neck and jawline that is just starting to sag. Its an ultrasound treatment that tightens existing collagen and promotes the growth of new collagen. It has zero downtime.

Some patients repeat the treatment every one to two years to keep their skin firm and tight. Which treatment is suitable for a person can be checked by their cosmetic plastic surgeon and a customised treatment plan can be made for best results.

With inputs fromDr Parag Telang,Plastic & Reconstructive Surgeon

Read the original here:
Anti-aging treatments by experts for women in their 40's - India TV News

Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults…

– In Adults with Pyruvate Kinase (PK) Deficiency Who Are Not Regularly Transfused, PYRUKYND® Significantly Increased Hemoglobin Level, Decreased Hemolysis and Improved Patient-Reported Outcomes –

Visit link:
Agios Announces Publication of Phase 3 ACTIVATE Study in New England Journal of Medicine Demonstrating Benefits of PYRUKYND® (mitapivat) for Adults...

Junshi Biosciences and Coherus Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States

SHANGHAI, China and REDWOOD CITY, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”) announced today that the United States Food and Drug Administration ("FDA") has granted Orphan Drug Designation (“ODD”) for toripalimab, a PD-1 inhibitor, for the treatment of small cell lung cancer (“SCLC”). ODD is granted to drugs intended to treat rare diseases with a patient population less than 200,000 in the United States. The designation provides incentives to advance development and commercialization of drugs that have the potential to provide benefit to patients with rare diseases.

Read this article:
Junshi Biosciences and Coherus Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer in the United States

BeyondSpring Files 2021 Annual Report on Form 20-F

NEW YORK, April 14, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a clinical stage global biopharmaceutical company focused on developing innovative cancer therapies to improve clinical outcomes for patients who have high unmet medical needs, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission (“SEC”) on April 14, 2022. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at www.sec.gov and on the Company’s website at www.beyondspringpharma.com under “Financials & Filings” in the Investors section.

Read the original post:
BeyondSpring Files 2021 Annual Report on Form 20-F

Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimer’s Symposium; International Frailty and Sarcopenia Research…

April events to highlight Longeveron’s commitment to developing cell therapeutics for chronic aging related diseases. April events to highlight Longeveron’s commitment to developing cell therapeutics for chronic aging related diseases.

More:
Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimer’s Symposium; International Frailty and Sarcopenia Research...

Virbac : Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good…

1 Growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of identical exchange rates (the exchange rate used is the previous financial year), and excluding change in scope, by calculating the indicator for the financial year in question on the basis of the scope of consolidation for the previous financial year.

Read this article:
Virbac : Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good...

Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that the company will participate in the public-private partnership Oncode-PACT, which will be supported by the National Growth Fund, an initiative of the Dutch Ministry of Economic Affairs and Climate Policy and the Ministry of Finance.

Originally posted here:
Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT